Moreover, in in vivo studies, we have shown induction of cell death and improved mice survival when a membrane-localizing cytotopically modified IL-15 was injected directly into prostate tumors (Papaevangelou et al., 2020). This evidence concerns the gene IL15 and prostate neoplasm.